Total employees
60
Harpoon Therapeutics is a clinical-stage immuno-oncology company focused on developing T cell engagers using proprietary platforms, including TriTAC® for solid tumors and hematologic malignancies. As of March 11, 2024, it is a subsidiary of Merck & Co., Inc.
Info powered by Clay
https://www.harpoontx.com/
View on LinkedIn
South San Francisco, California
Explore Clay
Clay Templates
Find more company data using our pre-built Clay templates.
Find Key Decision Makers
Find Number of Open Roles
Find International Employees
See all templates
Learn Clay
Go to our University library to get started and learn with our tutorials.
See all our tutorials
Explore more companies
Oops! Something went wrong while submitting the form.
Historical Data
employee per department
Scale your outbound motion in seconds, not months
14 day free Pro trial - No credit card required
Try Clay free